Project Brochures


OncoMark are actively involved in collaboration R&D projects focused on the identification of biomarkers in cancer progression and drug toxicity. Specifically, OncoMark participates in six EU FP7 research programmes. These include three Marie Curie Industry Academia Partners and Partnerships programmes: 'Target Melanoma', 'Angiotox' and 'FASTPATH' and the Cooperation Health programmes 'RATHER' and 'AngioPredict'. The 'APO-DECIDE' project is also funded as part of the European Framework Programme 7 collaborative project for small or medium scale focused research projects.

Please see below the overview PDF brochures for each of these projects.

Target Melanoma 1st page
Target Melanoma 1st page
Target Melanoma 2nd page
Target Melanoma 2nd page
RATHER 1st page
RATHER 1st page
RATHER 2nd page
RATHER 2nd page
AngioTox 1st page
AngioTox 1st page
AngioTox 2nd page
AngioTox 2nd page
AngioDecide 1st page
AngioDecide 1st page
AngioPredict 2nd page
AngioPredict 2nd page
Apo Decide 1st page
Apo Decide 1st page
Apo Decide 2nd page
Apo Decide 2nd page
FAST-PATH 1st page
FAST-PATH 1st page
FAST-PATH 2nd page
FAST-PATH 2nd page
SysMel 1st Page
SysMel 1st Page
SysMel 2nd Page
SysMel 2nd Page